Form 4 for MNPR Monopar Therapeutics
Accepted 2022-10-03 00:00:00 ET · period of report 2022-09-30 · accession 0001654954-22-013278 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-03 | 2022-09-30 | MNPR | Cittadine Andrew | COO | M - OptEx | — | +4,063 | 9,376 | +76% | — |
| D | 2022-10-03 | 2022-09-30 | MNPR | Cittadine Andrew | COO | F - Tax | $1.52 | -1,191 | 8,185 | -13% | -$1,810 |
| D | 2022-10-03 | 2022-09-30 | MNPR | Cittadine Andrew | COO | M - OptEx | $0.00 | -4,063 | 52.8K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-30 | M | A | 4,063 | — | 9,376 | D | — | — | (F1) Represents shares acquired on vesting and settlement of restricted stock units. |
| 2 | Common | Common Stock | 2022-09-30 | F | D | 1,191 | $1.52 | 8,185 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2022-09-30 | M | D | 4,063 | $0.00 | 52,812 | D | — · — to — | 4,063 Common Stock | (F1) Represents shares acquired on vesting and settlement of restricted stock units. (F2) On February 2, 2022, the reporting person was granted 65,000 restricted stock units, vesting 6/48ths (8,125 shares) on June 30, 2022, and 3/48ths (4,063 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. |